Bukwang Pharmaceutical Co., Ltd. (KRX: 003000)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,040.00
+10.00 (0.20%)
Oct 14, 2024, 10:59 AM KST

Bukwang Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-31,551-31,330-2,475-916.62-7,203-7,412
Upgrade
Depreciation & Amortization
4,1104,2925,1174,8436,1585,840
Upgrade
Loss (Gain) From Sale of Assets
-34.37-30.64-52.25-220.05-54.25-3.42
Upgrade
Asset Writedown & Restructuring Costs
4,658---3,539-
Upgrade
Loss (Gain) From Sale of Investments
-495.97564.4567.47-90.533,29711,791
Upgrade
Loss (Gain) on Equity Investments
935.651,501-58.571,3612,838783.95
Upgrade
Stock-Based Compensation
147.49147.4944.333.413,226348.34
Upgrade
Provision & Write-off of Bad Debts
-4,348-4,8972,9021,6941,2641,126
Upgrade
Other Operating Activities
-729.84-3,3733,261917.18-3,028-18,896
Upgrade
Change in Accounts Receivable
66,39457,117-423.7411,5546,663-9,759
Upgrade
Change in Inventory
-5,444-18,388208.4312,182-7,814-10,961
Upgrade
Change in Accounts Payable
-7,254-14,1609,154-2,735-1,1027,059
Upgrade
Change in Other Net Operating Assets
-4,647-806.65-1,782-2,066-7,060-3,323
Upgrade
Operating Cash Flow
21,740-9,36216,46126,525723.17-23,408
Upgrade
Operating Cash Flow Growth
---37.94%3567.88%--
Upgrade
Capital Expenditures
-1,491-2,835-4,298-785.05-1,917-3,538
Upgrade
Sale of Property, Plant & Equipment
141.27142.271.27388.4518,21534.45
Upgrade
Divestitures
12,161238.89----
Upgrade
Sale (Purchase) of Intangibles
262.19267.3-692.11-4.47-36.93-1,368
Upgrade
Investment in Securities
-1,760-152.851,5885,150-3,21322,956
Upgrade
Other Investing Activities
-238.8920180-00-0
Upgrade
Investing Cash Flow
9,075-2,319-3,1514,74913,04818,085
Upgrade
Short-Term Debt Issued
--10,000-96,30013,000
Upgrade
Long-Term Debt Issued
-80,000----
Upgrade
Total Debt Issued
90,00080,00010,000-96,30013,000
Upgrade
Short-Term Debt Repaid
---10,000-20,000-76,300-13,000
Upgrade
Long-Term Debt Repaid
--447.86-433.92-452.42-443.28-427.3
Upgrade
Total Debt Repaid
-73,713-447.86-10,434-20,452-76,743-13,427
Upgrade
Net Debt Issued (Repaid)
16,28779,552-433.92-20,45219,557-427.3
Upgrade
Issuance of Common Stock
--100---
Upgrade
Repurchase of Common Stock
----516.19-25,112-50,160
Upgrade
Dividends Paid
---6,845-6,225-12,190-9,774
Upgrade
Other Financing Activities
-4,570-2,714-469.66-290.9445,9782,880
Upgrade
Financing Cash Flow
11,71776,839-10,398-27,48528,232-57,481
Upgrade
Foreign Exchange Rate Adjustments
-1,625552.82-172.98-303.37-297.75-11.07
Upgrade
Miscellaneous Cash Flow Adjustments
-0-----
Upgrade
Net Cash Flow
40,90765,7102,7403,48641,706-62,815
Upgrade
Free Cash Flow
20,249-12,19612,16325,740-1,194-26,945
Upgrade
Free Cash Flow Growth
---52.75%---
Upgrade
Free Cash Flow Margin
17.37%-9.69%6.37%14.10%-0.70%-16.02%
Upgrade
Free Cash Flow Per Share
294.88-178.17177.68375.98-17.40-375.98
Upgrade
Cash Interest Paid
2,9951,139147.12290.94947.1421.07
Upgrade
Cash Income Tax Paid
-900.44,1168,9339,09329,628
Upgrade
Levered Free Cash Flow
30,04359,1499,28525,2411,316-23,535
Upgrade
Unlevered Free Cash Flow
32,42361,52910,38526,1212,263-23,478
Upgrade
Change in Net Working Capital
-51,685-83,239-10,403-18,5554,45830,373
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.